Challenges and Progress in Nonsteroidal Anti-Inflammatory Drugs Co-Crystal Development

Area of Science:

• Pharmaceutical Sciences
• Materials Science
• Green Chemistry

Background:

• Co-crystallization is a promising strategy in drug development for enhancing drug properties.
• It aligns with green pharmacy principles, aiming for safer and improved pharmaceutical products.
• Non-steroidal anti-inflammatory drugs (NSAID) are a key focus for co-crystal innovation due to their therapeutic importance and potential for property enhancement.

Purpose of the Study:

• To explore the potential of co-crystal innovation in drug development.
• To highlight co-crystallization as a method for creating novel patent drugs, especially NSAIDs.
• To discuss the challenges and advancements in developing commercially viable co-crystal drugs.

Main Methods:

• Review of co-crystallization principles and applications in drug formulation.
• Analysis of co-former selection strategies for NSAID co-crystals.
• Examination of methods development in co-crystal research.

Main Results:

• Co-crystallization improves physicochemical and mechanical properties of drugs via non-covalent interactions.
• Key challenges include co-former selection, decreased solubility, spring and parachute effect, pH effects, instability, and polymorphism.
• Continuous updates in co-former selection and methods development are observed for NSAID co-crystals.

Conclusions:

• Co-crystal innovation presents significant opportunities for drug development and the pharmaceutical industry.
• Overcoming challenges in co-crystal development is crucial for realizing their full therapeutic potential.
• Ongoing research and development in NSAID co-crystals are leading to improved drug formulations.